Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastases. Mills MN, Walker C, Thawani C, Naz A, et al. BMC Cancer 2021;21:223.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mills MN, Walker C, Thawani C, Naz A, et al. Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastases. BMC Cancer 2021;21:223.
PMID: 33663447